Standard BioTools
LAB
LAB
142 hedge funds and large institutions have $487M invested in Standard BioTools in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $543M → $487M (-$55.5M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
93% less call options, than puts
Call options by funds: $12K | Put options by funds: $178K
Holders
142
Holding in Top 10
3
Calls
$12K
Puts
$178K
Top Buyers
| 1 | +$5.48M | |
| 2 | +$4.21M | |
| 3 | +$3.73M | |
| 4 |
Morgan Stanley
New York
|
+$2.81M |
| 5 |
RA
Royce & Associates
New York
|
+$1.47M |
Top Sellers
| 1 | -$9.85M | |
| 2 | -$5.18M | |
| 3 | -$5.14M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$4.06M |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$528K |